Ces Urol 2005, 9(3):16-19 | DOI: 10.48095/cccu2005016

Didymal tumours from leydig and sertoli cells

L. Hyršl1, J. Abrahámová2, A. Zuntová3, I. Kawaciuk1, P. Dušek1
1 Urologická klinika 2. LF UK Praha a FN Motol, Praha
2 Onkologické oddělení FTN, Praha
3 Ústav patologie a molekulární medicíny 2. LF UK a FN Motol, Praha

The authors present their own experience with diagnostics and treatment in five patients with Leydig cell tumors (LCT) and one patient with Sertoli cell tumors (SCT). Ultrasonography appears an excellent diagnostic method in testicular tumors. Blood markers (AFP, ß-hCG), estradiol and testosterone help to confirm diagnosis of LCT and SCT. Radical orchiectomy is the initial treatment of choice. Retroperitoneal lymph node dissection is reccomended for malignant lesions with nodal involvement because of chemoresistance and radioresistance. All patients must be observed for a long period.

Keywords: Leydig cell tumour, Sertoli cell tumour, symptoms, diagnostic criteria, treatment

Published: June 1, 2005 

Open full article

References

  1. Sesterhenn IA, Cheville J, Woodward PJ, Damjanov I, Jacobsen GK, Nistal M, Paniagua R, Renshaw AA. Sex cord/gonadal tumours. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics of tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press 2004: 250-258.
  2. Dounis A, Papacharalampous A. Clinically occult Leydig cell tumor in cryptorchid man. Eur Urol 1997; 32: 368-370. Go to original source...
  3. Bujan L, Mieusset R, De Zong Z, Mansat A, Pontonnier F. Development of Leydig cell tumour in Association with Clomiphene treatment for oligozoospermia. Br J Urol 1992; 69: 659-660. Go to original source... Go to PubMed...
  4. Bokemeyer C, Kuczyk M, Schoffski P, Schmoll HJ. Familial occurence of Leydig cell tumors: a report of a case in a father and his adult son. J Urol 1993; 150, 5. Pt 1: 1509-1510. Go to original source... Go to PubMed...
  5. Gana BM, Windsor PM, Lang S, MacIntyre J, Baxby K. Leydig cell tumour. Br J Urol 1995; 75: 676-678. Go to original source... Go to PubMed...
  6. Palazzo JP, Petersen RO, Young RH, Scully RE. Deoxyribonucleic acid flow cytometry of testicular Leydig cell tumors. J Urol 1994; 152, 2. Pt 1: 415-417. Go to original source... Go to PubMed...
  7. Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM. Leydig cell tumor of the testis: a clinicopathologic DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. Am J Surg Pathol 1998; 22: 1361-1367. Go to original source... Go to PubMed...
  8. McCluggage WG, Shanks JH, Arthur K, Banerjee SS. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours. Histopathology 1998; 33: 361-368. Go to original source... Go to PubMed...
  9. Naughton CK, Nadler RB, Basler JW, Humphrey PA. Leydig cell hyperplasia. Br J Urol 1998; 81: 282-289. Go to original source... Go to PubMed...
  10. Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. Am J Surg Pathol 1985; 9: 177-192. Go to original source... Go to PubMed...
  11. Grem JL, Robins HD, Wilson NK, Gilchrist L, Trump DL. Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature. Cancer 1986; 58: 2116-2119. Go to original source... Go to PubMed...
  12. Horňák M, Matoška J. Nádory testis diagnostika a liečba. Bratislava: Veda 1990: 63-90.
  13. Ahsan Z, Maloney JL, English PJ. Metastasis to skin from Leydig cell tumour. Br J Urol 1993; 72: 510-511. Go to original source... Go to PubMed...
  14. Young RH, Koelliker DD, Scully RE. Sertoli cell tumors of the testis, not otherwise specified: A clinicopathologic analysis of 60 cases. Am J Surg Pathol 1998; 22: 709-721. Go to original source... Go to PubMed...
  15. Anderson GA. Sclerosing Sertoli cell tumor of the testis: A distinct histological subtype. J Urol 1995; 154: 1756-1758. Go to original source... Go to PubMed...
  16. Gabrilove JL, Freiberg EK, Leiter E, Nicolis GL. Feminizing and non-feminizing Sertoli cell tumors. J Urol 1980; 124: 757-767. Go to original source... Go to PubMed...
  17. Fallick ML, Lin WW, Lipshultz LI. Leydig cell tumors presenting as azoospermia. J Urol 1999; 161: 1571-1572. Go to original source... Go to PubMed...
  18. Wegner HEH, Herbst H, Andresen R, Dieckmann KP. Leydig cell tumor recurrence after enucleation. J Urol 1996; 156: 1443-1444. Go to original source... Go to PubMed...
  19. Wegner HE, Dieckmann KP, Herbst H, Andresen R, Miller K. Leydig cell tumor-comparison of results of radical and testis-sparing surgery in a single center. Urol Int 1997; 59: 170-173. Go to original source... Go to PubMed...
  20. Azer PC, Braunstein GD. Malignant Leydig cell tumor: objective tumor response to o,p'-DDD. Cancor 1981; 47: 1251-1255. Go to original source...
  21. Van der Hem KG, Boven E, Van Hennik MB, Pinedo HM. Malignant Leydig cell tumor of the testis in complete remission on o,p ́-dichlorodiphenyl-dichloroethane. J Urol 1992; 148: 1256-1259. Go to original source... Go to PubMed...

Return to the content



Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.


Odejít Vstoupit